Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) Assets Average (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Assets Average data on record, last reported at $170.7 million in Q3 2025.

  • For Q3 2025, Assets Average rose 25.12% year-over-year to $170.7 million; the TTM value through Sep 2025 reached $170.7 million, up 25.12%, while the annual FY2024 figure was $155.9 million, 32.5% down from the prior year.
  • Assets Average reached $170.7 million in Q3 2025 per FBIO's latest filing, up from $169.0 million in the prior quarter.
  • Across five years, Assets Average topped out at $413.0 million in Q3 2021 and bottomed at $135.7 million in Q4 2024.
  • Average Assets Average over 5 years is $259.2 million, with a median of $222.1 million recorded in 2023.
  • Peak YoY movement for Assets Average: skyrocketed 62.71% in 2021, then tumbled 40.46% in 2024.
  • A 5-year view of Assets Average shows it stood at $402.2 million in 2021, then fell by 23.18% to $308.9 million in 2022, then decreased by 28.1% to $222.1 million in 2023, then tumbled by 38.93% to $135.7 million in 2024, then increased by 25.8% to $170.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Assets Average were $170.7 million in Q3 2025, $169.0 million in Q2 2025, and $161.1 million in Q1 2025.